Moderna:获得美国食品药品监督管理局(FDA)批准其新冠病毒疫苗MNEXSPIKE。预计将在2025-2026年呼吸道病毒季节为符合条件的美国人群提供MNEXSPIKE疫苗。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.